Drugs / NMDAE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04745143 | Jan 2018 → Sep 2027 expected | schizophrenia | China Medical University Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NMDAE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04745143 ↗ |
| Action | Activate | “NMDA-enhancing agent” NCT04745143 ↗ |